Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
agilon health, inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/16/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/08/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "agilon health Reports Second Quarter 2023 Results"
05/25/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/18/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Underwriting Agreement, among agilon health, inc., the selling stockholders named therein and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and BofA Securities, Inc., as representatives of the several underwriters name therein"
05/17/2023 424B7 Form 424B7 - Prospectus [Rule 424(b)(7)]:
05/16/2023 144 Form 144 - Report of proposed sale of securities:
05/16/2023 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
05/15/2023 424B7 Form 424B7 - Prospectus [Rule 424(b)(7)]:
05/15/2023 144 Form 144 - Report of proposed sale of securities:
05/12/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Quarterly results
Docs: "Investor Contact"
04/20/2023 144 Form 144 - Report of proposed sale of securities:
04/19/2023 144 Form 144 - Report of proposed sale of securities:
04/14/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/14/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/24/2023 144 Form 144 - Report of proposed sale of securities:
03/23/2023 144 Form 144 - Report of proposed sale of securities:
03/10/2023 SC 13G/A Capital World Investors reports a 10.3% stake in Agilon Health, Inc.
03/01/2023 8-K Quarterly results
Docs: "Investor Contact"
02/22/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/08/2023 SC 13G/A MORGAN STANLEY reports a 9.1% stake in agilon health, inc.
02/06/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/10/2023 SC 13G/A FMR LLC reports a 11.3% stake in AGILON HEALTH INC
01/09/2023 8-K Regulation FD Disclosure  Interactive Data
12/20/2022 8-K Resignation/termination of a director
11/03/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/03/2022 8-K Quarterly results
09/30/2022 8-K Quarterly results
08/10/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy